LeMaitre Vascular ROE 2010-2025 | LMAT
Current and historical return on equity (ROE) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LeMaitre Vascular ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.05B | $0.35B | 13.47% |
| 2024-12-31 | $0.04B | $0.34B | 13.57% |
| 2024-09-30 | $0.04B | $0.33B | 13.04% |
| 2024-06-30 | $0.04B | $0.32B | 12.50% |
| 2024-03-31 | $0.03B | $0.31B | 11.53% |
| 2023-12-31 | $0.03B | $0.30B | 10.48% |
| 2023-09-30 | $0.03B | $0.29B | 10.04% |
| 2023-06-30 | $0.03B | $0.28B | 9.20% |
| 2023-03-31 | $0.02B | $0.27B | 7.92% |
| 2022-12-31 | $0.02B | $0.27B | 8.04% |
| 2022-09-30 | $0.02B | $0.26B | 8.15% |
| 2022-06-30 | $0.02B | $0.26B | 9.03% |
| 2022-03-31 | $0.03B | $0.26B | 11.40% |
| 2021-12-31 | $0.03B | $0.25B | 12.46% |
| 2021-09-30 | $0.03B | $0.25B | 14.25% |
| 2021-06-30 | $0.03B | $0.19B | 16.62% |
| 2021-03-31 | $0.03B | $0.18B | 15.04% |
| 2020-12-31 | $0.02B | $0.17B | 13.84% |
| 2020-09-30 | $0.02B | $0.16B | 13.09% |
| 2020-06-30 | $0.02B | $0.15B | 11.49% |
| 2020-03-31 | $0.02B | $0.15B | 12.48% |
| 2019-12-31 | $0.02B | $0.15B | 13.55% |
| 2019-09-30 | $0.02B | $0.14B | 14.73% |
| 2019-06-30 | $0.02B | $0.14B | 14.45% |
| 2019-03-31 | $0.02B | $0.13B | 18.07% |
| 2018-12-31 | $0.02B | $0.13B | 18.81% |
| 2018-09-30 | $0.02B | $0.13B | 17.91% |
| 2018-06-30 | $0.02B | $0.12B | 19.56% |
| 2018-03-31 | $0.02B | $0.11B | 16.86% |
| 2017-12-31 | $0.02B | $0.11B | 16.75% |
| 2017-09-30 | $0.02B | $0.11B | 16.67% |
| 2017-06-30 | $0.01B | $0.10B | 15.34% |
| 2017-03-31 | $0.01B | $0.09B | 13.71% |
| 2016-12-31 | $0.01B | $0.09B | 12.98% |
| 2016-09-30 | $0.01B | $0.09B | 13.37% |
| 2016-06-30 | $0.01B | $0.08B | 12.66% |
| 2016-03-31 | $0.01B | $0.08B | 11.88% |
| 2015-12-31 | $0.01B | $0.08B | 11.03% |
| 2015-09-30 | $0.01B | $0.07B | 10.00% |
| 2015-06-30 | $0.01B | $0.07B | 8.79% |
| 2015-03-31 | $0.01B | $0.07B | 7.38% |
| 2014-12-31 | $0.00B | $0.07B | 6.18% |
| 2014-09-30 | $0.00B | $0.07B | 4.84% |
| 2014-06-30 | $0.00B | $0.07B | 5.08% |
| 2014-03-31 | $0.00B | $0.06B | 5.41% |
| 2013-12-31 | $0.00B | $0.06B | 7.31% |
| 2013-09-30 | $0.00B | $0.06B | 7.44% |
| 2013-06-30 | $0.00B | $0.05B | 7.55% |
| 2013-03-31 | $0.00B | $0.05B | 7.62% |
| 2012-12-31 | $0.00B | $0.05B | 5.74% |
| 2012-09-30 | $0.00B | $0.05B | 3.85% |
| 2012-06-30 | $0.00B | $0.05B | 3.83% |
| 2012-03-31 | $0.00B | $0.05B | 3.81% |
| 2011-12-31 | $0.00B | $0.05B | 3.81% |
| 2011-09-30 | $0.00B | $0.05B | 7.62% |
| 2011-06-30 | $0.01B | $0.05B | 9.62% |
| 2011-03-31 | $0.01B | $0.05B | 11.76% |
| 2010-12-31 | $0.01B | $0.05B | 13.93% |
| 2010-09-30 | $0.01B | $0.05B | 12.18% |
| 2010-06-30 | $0.01B | $0.05B | 10.36% |
| 2010-03-31 | $0.00B | $0.05B | 8.42% |
| 2009-12-31 | $0.00B | $0.05B | 2.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.839B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.401B | 28.55 |
| Boston Scientific (BSX) | United States | $145.814B | 36.50 |
| Stryker (SYK) | United States | $145.229B | 30.37 |
| EssilorLuxottica (ESLOY) | France | $130.605B | 0.00 |
| Medtronic (MDT) | Ireland | $113.492B | 16.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.916B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.556B | 28.23 |
| ResMed (RMD) | United States | $36.981B | 27.78 |
| Agilent Technologies (A) | United States | $33.778B | 22.02 |
| GE HealthCare Technologies (GEHC) | United States | $33.476B | 15.89 |
| Terumo (TRUMY) | Japan | $27.213B | 35.35 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.367B | 83.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.85 |
| Baxter (BAX) | United States | $16.093B | 12.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.187B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.325B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 13.99 |
| Prestige Consumer Healthcare (PBH) | United States | $4.207B | 18.80 |
| Perrigo (PRGO) | Ireland | $3.746B | 9.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.428B | 15.61 |
| ICU Medical (ICUI) | United States | $3.258B | 24.02 |
| Envista Holdings (NVST) | United States | $3.198B | 26.58 |
| GN Store Nord (GNNDY) | Denmark | $2.319B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.021B | 13.90 |
| AtriCure (ATRC) | United States | $1.600B | 0.00 |
| Acuren (TIC) | United States | $1.308B | 0.00 |
| Neogen (NEOG) | United States | $1.220B | 15.61 |
| AdaptHealth (AHCO) | United States | $1.187B | 12.05 |
| BioLife Solutions (BLFS) | United States | $1.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.061B | 23.86 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.963B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 8.95 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.656B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.637B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.576B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.419B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.92 |
| Aurora Cannabis (ACB) | Canada | $0.342B | 60.90 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.60 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanara MedTech (SMTI) | United States | $0.255B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.08 |
| Brainsway (BWAY) | Israel | $0.216B | 57.10 |
| TriSalus Life Sciences (TLSI) | United States | $0.208B | 0.00 |
| Omeros (OMER) | United States | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.51 |
| Jin Medical (ZJYL) | China | $0.109B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.29 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |